Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI

NCT03664180 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

2989

Enrollment

OTHER

Sponsor class

Conditions

STEMI - ST Elevation Myocardial Infarction

Interventions

DRUG: Bivalirudin
DRUG: Enoxaparin
DRUG: Unfractionated heparin
DRUG: Bivalirudin placebo
DRUG: Enoxaparin placebo syringe
DRUG: Unfractionated heparin placebo

Sponsor

Beijing Anzhen Hospital

Collaborators

[object Object]
[object Object]